[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Umberto Tirelli
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Advocacy[edit | edit source]
- 1991 - founded CFS Associazione Italiana onlus , a patient association for chronic fatigue syndrome in Italy
Notable studies[edit | edit source]
- 1996, Immunologic Abnormalities in Chronic Fatigue Syndrome[1] - (Abstract)
- 2018, Oxygen-Ozone therapy is a potentially effective therapy in Chronic Fatigue Syndrome: Results of an Italian study in 65 patients[2] - (Abstract)
- 2022, Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy[3] - (Full text)
See also[edit | edit source]
References[edit | edit source]
- ↑ Umberto Tirelli, Daniele Bernardi, Salvatore Improta & Antonio Pinto. (1996). Immunologic Abnormalities in Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 2, Iss. 1, pp 85-96. http://dx.doi.org/10.1300/J092v02n01_07
- ↑ Tirelli, Umberto; Cirrito, Cinzia; Pavanello, Martina; Lleshi, Arben; Franzini, Marianno (July 25, 2018). "OXYGEN-OZONE THERAPY IS A POTENTIALLY EFFECTIVE THERAPY IN CHRONIC FATIGUE SYNDROME: RESULTS OF AN ITALIAN STUDY IN 65 PATIENTS". GLOBAL JOURNAL FOR RESEARCH ANALYSIS. 7 (5).
- ↑ Tirelli, Umberto; Franzini, Marianno; Valdenassi, Luigi; Pandolfi, Sergio; Berretta, Massimiliano; Ricevuti, Giovanni; Chirumbolo, Salvatore (January 2022). "Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy". Journal of Clinical Medicine. 11 (1): 29. doi:10.3390/jcm11010029. PMC 8745272. PMID 35011770.
